Concord Drugs Ltd Half Yearly Results

Gross Sales

28.43

16.5

25.83

26.25

Excise Duty

0

0

0

0

Net Sales

28.43

16.5

25.83

26.25

Other Operating Income

0

0.01

0

0.01

Other Income

0

0

0

0

Total Income

28.43

16.51

25.84

26.25

Total Expenditure

27.45

13.43

23.42

24.09

PBIDT

0.98

3.07

2.41

2.17

Interest

1

0.87

0.95

0.76

PBDT

-0.02

2.2

1.47

1.41

Depreciation

0.78

0.77

0.71

0.92

Minority Interest Before NP

0

0

0

0

Tax

-0.2

0.42

0.22

0.16

Deferred Tax

-0.02

-0.04

-0.08

-0.03

Reported Profit After Tax

-0.58

1.05

0.62

0.37

Minority Interest After NP

0

0

0

0

Net Profit after Minority Interest

-0.58

1.05

0.62

0.37

Extra-ordinary Items

0

0

0

0

Adjusted Profit After Extra-ordinary item

-0.58

1.05

0.62

0.37

EPS (Unit Curr.)

0

1.13

0.66

0.42

Book Value (Unit Curr.)

0

0

0

0

Dividend (%)

0

0

0

0

Equity

10

9.32

9.32

8.74

Public Shareholding (Number)

0

0

0

0

Public Shareholding (%)

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

PBIDTM(%)

3.44

18.6

9.33

8.26

PBDTM(%)

-

-

-

-

PATM(%)

-2.04

6.36

2.4

1.4